Physician profile
Ran Schwarzkopf
NPI 1407016488
$2,036,695.00
in general payments reported to CMS, 2019-2025
15 companies · $429K in 2025
The $429K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200K · 2020: $124K · 2021: $183K · 2022: $249K · 2023: $393K · 2024: $458K · 2025: $429K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $439K · Consulting Fee: $423K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $310K · Travel and Lodging: $92K · Food and Beverage: $16K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $439,347.25 |
| Consulting Fee | $423,303.49 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $309,686.00 |
| Travel and Lodging | $92,339.05 |
| Food and Beverage | $15,599.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,880,573.98 | 2019-2025 | Journey II, Real Intelligence, Navio |
| Zimmer Biomet Holdings, INC. | $78,035.88 | 2021-2025 | Persona |
| Stryker Corporation | $35,593.23 | 2019-2025 | Mako |
| Intellijoint Surgical INC. | $21,507.01 | 2019-2024 | Intellijoint Hip, Intelljoint |
| Microport Orthopedics INC | $6,751.43 | 2021-2024 | Mpo Medial Pivot Knee |
| Pacira Pharmaceuticals Incorporated | $4,866.57 | 2019 | |
| Convatec INC. | $4,500.00 | 2025 | |
| Heraeus Medical, LLC. | $3,580.58 | 2020-2024 | |
| Innovation Technologies INC | $400.07 | 2023-2025 | Irrisept |
| Medtronic USA, INC. | $341.22 | 2019 | |
| Davol INC. | $254.64 | 2024-2025 | Arista Ah Flexitip, Arista |
| Uoc USA INC | $159.17 | 2021 | |
| Horizon Therapeutics Plc | $111.22 | 2019 | |
| Bone Support INC. | $20.00 | 2025 | Cerament G, Ceramentbone Void Filler |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,217,878.10 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ran Schwarzkopf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.